Oxytocin versus Tranexamic acid and Ethamsylate
- Conditions
- blood loss
- Registration Number
- PACTR202101794541918
- Lead Sponsor
- Sayed Galal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 230
1-Pregnant females admitted for elective Cesarean Section
2-Gestational age (38 to 41 weeks)
3- Age of the participants: 20y to 40 years
4- Body Mass Index (18.5 - 29.9)
5-Singleton living fetus.
6-No medical disorders.
1 - Medical and surgical disorders as thyroid dysfunction, which was excluded by routine thyroid function test (free T3, free T4, and thyroid-stimulating hormone(TSH), all of them should be within normal limits).
2 -Bleeding tendency, was excluded by platelet count, coagulation time, bleeding time, prothrombin time, partial thromboplastin time, and thrombin time (all should be within normal).
3 -Acute and chronic liver or kidney diseases; blood disorders, such as anemia.
4 -Allergy to Tranexamic acid or any drug used.
5 -Risk factors for PPH, such as polyhydramnios, fetal macrosomia, antepartum hemorrhage.
6 - Abnormal placentae such as placenta previa and placental abruption.
7 -Pregnancy complications such as severe pre-eclampsia, Gestational HTN, Gestational DM, and multi Fetal pregnancies, those requiring blood transfusion.
8 - Patients who refused spinal anesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method